Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
persephone.borrow@immonc.ox.ac.uk
persephone.borrow@ndm.ox.ac.uk

Research groups

Rational Vaccine Development- Borrow Group

Persephone Borrow

PhD

PROFESSOR OF VIRAL IMMUNOLOGY, Group Leader

Recent publications

An HIV-1 gp41 MPER liposome vaccine elicits neutralizing epitope-targeted antibody responses in HIV-seronegative individuals

Borrow P. and Aflalo A., (2026), Nature Communications

SorLA regulates B cell receptor uptake, trafficking, and B cell-mediated immune responses in vivo

Borrow P. et al, (2026), Journal of Experimental Medicine (JEM)

HLA-E-restricted T cells primed by a modified HLA-B*57:01 restricted HIV-1 peptide suppress HIV-1 replication.

Sun H. et al, (2026), JCI insight

What if Every Patient’s Immune System Could be Guided by the World’s Most Powerful Computers to Fight Cancer? The UK Cancer Vaccines AI and Supercompute Project

Bryan ME. et al, (2026), EMJ Innovation, 10, 74 - 79

Targeting MHC-E as a new strategy for vaccines and immunotherapeutics.

Früh K. et al, (2026), Nature reviews. Immunology, 26, 52 - 66

More publications